Beranda › Kardiomiopati Hipertrofik › Missouri
Uji klinis Kardiomiopati Hipertrofik di Missouri
3 studi untuk Kardiomiopati Hipertrofik mencari peserta di lokasi di Missouri.
Teks studi resmi (Bahasa Inggris)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05489705Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
- St. Luke's Hospital - Mid America Heart Institute, Kansas City
Menerima pesertaFase 4
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT07600177A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT07023614Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.